LAFYX
Price
$20.04
Change
+$0.14 (+0.70%)
Updated
Jul 3 closing price
Net Assets
6.22B
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

LAFYX vs VVIAX

Header iconLAFYX vs VVIAX Comparison
Open Charts LAFYX vs VVIAXBanner chart's image
Lord Abbett Affiliated I
Price$20.04
Change+$0.14 (+0.70%)
VolumeN/A
Net Assets6.22B
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
LAFYX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LAFYX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAFYX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. LAFYX (6.22B). VVIAX pays higher dividends than LAFYX: VVIAX (2.18) vs LAFYX (1.68). LAFYX was incepted earlier than VVIAX: LAFYX (27 years) vs VVIAX (25 years). LAFYX (0.44) is less costly to investors than VVIAX (0.05). LAFYX is a more actively managed with annual turnover of: 44.00 vs. VVIAX (9.00). VVIAX has a lower initial minimum investment than LAFYX: VVIAX (3000) vs LAFYX (1000000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. LAFYX (10.72). VVIAX return over 5 years is better than : 80.13 vs. LAFYX (63.61).
LAFYXVVIAXLAFYX / VVIAX
Total Expense Ratio0.440.05880%
Annual Report Gross Expense Ratio0.440.05880%
Fund Existence27 years25 years-
Gain YTD7.7816.198126%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets6.22B189B3%
Annual Yield % from dividends1.682.1877%
Returns for 1 year10.7212.0389%
Returns for 3 years33.5235.1795%
Returns for 5 years63.6180.1379%
Returns for 10 years43.86115.6738%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.